Very Urgent Intervention for Symptomatic Carotid Disease Linked to Increased Stroke Risk

 

November 29, 2018—A new meta-analysis shows that very urgent carotid artery intervention for the treatment of symptomatic carotid artery disease was associated with an increased risk of stroke within 30 days. The meta-analysis was published by David Milgrom, MD, et al in European Journal of Vascular & Endovascular Surgery (EJVES; 2018;56:622–631).

As reported in EJVES, the investigators set out to examine the outcomes of very urgent (defined as < 48 hours from a neurological event) versus urgent (defined as > 48 hours from a neurological event) carotid intervention to treat symptomatic carotid disease.

Researchers collected periprocedural outcome data on carotid intervention in relation to the length of time from the neurologic event from 12 observational studies and one randomized controlled trial. In total, 5,751 interventions, 5,385 carotid endarterectomies, and 366 carotid artery stenting procedures were included in the quantitative analysis.

Primary endpoints were defined as ipsilateral stroke and death; secondary endpoints were transient ischemic attack (TIA) and myocardial infarction (MI).

When compared with urgent carotid intervention, very urgent carotid intervention was associated with increased risk of stroke within 30 days (odds ratio [OR], 2.19; 95% confidence interval [CI], 1.46–3.26; P < .001). No significant difference in mortality (OR, 1.55; 95% CI, 0.81–2.96; P = .19), TIA (OR, 1.33; 95% CI, 0.55–3.19; P = .52), or MI (OR, 1.33; 95% CI, 0.41–4.33; P = .64) was shown, reported investigators in EJVES.

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.